The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Tregs

  • Post
    jim Breitfeller
    Participant

      One of many immunotolerance mechanisms that immune system has developed to distinguish between self and non-self antigens is regulatory T cells or Tregs.

      One of many immunotolerance mechanisms that immune system has developed to distinguish between self and non-self antigens is regulatory T cells or Tregs.

      These cells are recently characterized specialized T-cell subsets that actively suppress a variety of immune responses. Researchers have broadly classified Tregs into natural and adaptive Tregs. Natural Tregs are CD4+CD25+ T-cells that originate in the thymus and play a significant role in immune homeostasis and protection against autoimmunity. Adaptive Tregs are non-regulatory CD4+ T-cells that have up-regulated CD25 expression during pathological and inflammatory conditions such as cancers and infections.


      Although the principal immunosuppressive mechanism of Tregs remains elusive, several in vivo experimental models have indicated that Tregs secrete large amounts of immunosuppressants including IL-9, IL-10 and TGF-Beta; upon activation.

       

      These lymphokines are capable of inhibiting activation of Th1, Th2 cells and CTLs required for cell-mediated immunity, inflammation and antibody production. Certain recent experimental data and results even indicate that IL-2-IL-2R signaling is vital for development, maintenance, survival, expansion and suppressive activity of Tregs. Increased expression of certain other characteristic markers including CTLA-4, glucocorticoid-inducible tumor necrosis factor receptor (GITR) and OX40 has been identified on Tregs whose function inside these cells is still not clear. The TCRs displayed on Tregs are capable of recognizing and interacting with any peptide-MHC class II ligand having certain range of avidity. But, the contribution of TCR signaling and role of TCR-ligand interactions towards regulatory T-cell development needs to be determined.

       

    Viewing 0 reply threads
    • Replies
        talian44
        Guest

          Hi Jim

          I really appreciate your analysis and your genius. Please keep us informed.

          I have read most of your postings and even though I admit to a miniscule understanding of your writings, my gut tells me that you are onto something vitally important.

          Do you still subscribe to the importance of the sequencing of ipi and then IL-2 and how do you figure out the timing gap between the administering of the two drugs?

          kind regards

          miket or talian44

            jim Breitfeller
            Participant

              The science is coming in loud and clear. Remember I said blame it on the Tregs!!!!! Well Here is some conformation of that.

              Tamed T-Cells leave patients cancer-free
              Monday, 26 July 2010by Becky Crew

              The antigen-specific reaction of T-cells working with dendritic cells, which regulate the immune system.

              SYDNEY: The manipulation of specific immune cells in bone marrow transplants has left a number of patients cancer-free, giving new hope to leukemia and lymphoma sufferers, according to a recent study.

              A team lead by Sébastien Maury from the Service d’Hématologie Clinique, France, has shown for the first time that by depleting the regulatory T-cell (or Treg) population in donor tissue, patients suffering from very resistant forms of cancer can achieve complete remission.

              By identifying the Tregs’ influence on how a new immune system reacts to foreign elements, it’s hoped that this study will result in more successful cancer treatments using transplantation.

              Source: http://www.cosmosmagazine.com/news/3586/tamed-t-cells-leave-patients-cancer-free

              This study is proof of a concept which demonstrates that regulatory T-cell manipulation can have therapeutic effects in humans,” says Maury. “It opens the way to its application in various fields in medicine where the immune system needs to be ‘tolerised’ (by adding more regulatory T-cells) in autoimmune diseases or ‘un-tolerised’ (by their elimination) in cancer.”

              This Treg manipulation can be accomplished by Ipilimumab. Blocking the CTLA-4 receptor on the Tregs surpressing their tolarance.

              JerryfromFauq
              Participant

                Sounds god.  Now to get more work done to get this line activated in more treatments!

                JerryfromFauq
                Participant

                  Sounds god.  Now to get more work done to get this line activated in more treatments!

            Viewing 0 reply threads
            • You must be logged in to reply to this topic.
            About the MRF Patient Forum

            The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

            The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.